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Abstract: Human metabolism is investigated using several in vitro methods. However, the current
methodologies are often expensive, tedious and complicated. Over the last decade, the combination of
electrochemistry (EC) with mass spectrometry (MS) has a simpler and a cheaper alternative to mimic
the human metabolism. This paper describes the development of a disposable microfluidic device
with a screen-printed electrode (SPE) for monitoring phase II GSH reactions. The proposed chip has
the potential to be used as a primary screening tool, thus complementing the current in vitro methods.
Keywords: metabolism; electrochemistry; screen-printed electrodes; mass spectrometry
1. Introduction
Metabolism is a physiological process occurring in the liver, which enhances the elimination of
both endogenous and exogenous compounds. Metabolites are formed during phase I and phase II
metabolic reactions [1,2]. During natural conditions, phase I metabolites conjugate with glutathione
(GSH)—a reaction catalysed by glutathione S-transferases (GSTs)—and are detoxified (phase II
reactions) [3–5]. However, during phase I reactions, reactive metabolites can form, some of which are
toxic to DNA and proteins [6,7]. Currently, in vitro methodologies are expensive and involve lengthy
experimental procedures [8].
Direct electrochemistry in electrochemical flow cells can mimic the catalytic activity of CYP 450
in a cost effective manner [9]. In this technique, metabolites are synthesized electrochemically
on the working electrode and detected by mass spectrometry (MS) either intact or as phase
II GSH-adducts [10], depending on the application. Acetaminophen (APAP) and dopamine
(DOPA) are electroactive compounds with well-known metabolic routes that are widely used in
the field [11–13]. In 1989, Getek et al. generated and detected GSH conjugates of APAP by
coupling online an electrochemical flow cell with a thermospray mass spectrometer. The reactive
metabolite N-acetyl-p-benzoquinone imine (NAPQI) was formed in the electrochemical cell and
reacted subsequently with GSH in a mixing tee [14]. Lohhmann et al. [15], used a commercially
available cell equipped with a glassy carbon working electrode, a Pd/H2 reference electrode and
a Pd counter electrode. The isomeric adducts of APAP were obtained and detected by liquid
chromatography (LC)/mass spectrometry (MS). More recently, a miniaturized electrochemical cell with
high conversional rates was developed by Van den Brink et al. [16]. The microfluidic device had a dual
application, either the generation of short lived metabolites or the formation of GSH-adduct via the
addition of a T-piece on the effluent of chip. However, flow cells and glass microfluidics are fabricated
from expensive materials and require tedious cleaning methods for their reuse. A cost effective polymer
chip for electrochemical tagging was fabricated by Roussel et al. [17]. The electrospray emitter was
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developed with a microchannel and an integrated carbon electrode. The electrode surface-to-volume
ratio was 50 m−1 providing an efficient electrolytic cell for both electrochemical reactions and mass
spectrometric detections. Screen-printed electrodes (SPEs) are commercially available disposable
sensors, which can also be readily custom-made. The fabrication process relies on the screen printing
technique, involving the deposition of ink or paste onto a ceramic, glass, or plastic substrate [18–21].
SPEs are becoming widely applied in the field of electrochemistry due to their simplicity, portability,
low cost, mass production, and miniaturized format [21].
Kauffmann et al. [21] used a carbon SPE instead of a conventional flow cell for electrochemically
mimicking the metabolism of APAP. The sensor included all the required electrodes—including the
working, reference, and counter electrodes—resulting in an alternative miniaturized cell. The reactive
metabolite of APAP, the NAPQI, was generated on the working area of the SPE in the presence
of excess GSH concentration. NAPQI was covalently bonded with GSH, leading to the formation
of an APAP-GSH phase II adduct. The resulting phase II adduct was detected offline by liquid
chromatography (LC)/ESI-MS. Thus, the development of a primary screening tool with an SPE can
complement the in vitro methods, saving both time and cost. In the present study, we describe the
integration of a commercially available sensor (DS-110: DropSens, Oviedo, Spain) with a serpentine
reaction channel into a disposable polymeric chip, for mimicking phase II GSH reactions. A cheaper
alternative towards the existing flow cells and glass microfluidic chips without the need of any
tedious cleaning processes. In addition, the electrochemical step is separated from the ionization
process, as seen in the previous polymeric design [17], ensuring that the generated metabolites are
electrochemically driven and not the result of ionization. DOPA was used as a probe compound for
monitoring the phase II GSH reactions. According to the literature, dopaminoquinone is the reactive
intermediate of DOPA and probably the causal agent of Parkinson’s disease [22].
2. Experimental Section
2.1. Chemical Reagents
DOPA and GSH were purchased from Sigma Aldrich (Gillingham, UK). APAP was obtained by
Alfa Aesar (Heysham, UK). Buffers of different pH values were prepared using ammonium acetate
(Fisher scientific, Loughborough, UK), sodium phosphate dibasic (Sigma Aldrich), and potassium
phosphate monobasic (Sigma Aldrich). The reagents were used as received without any additional
purification. All solutions were degassed with pure nitrogen (99.9%) for 15 min prior to electrochemical
measurements. The water was deionised using an Elgastat prima 3 reverse osmosis unit (Elga Ltd.,
High Wycombe, UK).
2.2. Instrumentation
The electrochemical measurements were recorded using an SP-50 potentiostat (Bio-Logic, Claix,
France) and a PalmSens 3 potentiostat (Alvatek, Tetbury, UK). Metabolites were identified by ESI/MS
using a LCQ Classic ion trap mass spectrometer (Thermo Scientific, Hemel Hempstead, UK). A syringe
pump MD-1002 pursued from Basi (West Lafagette, IN, USA) was used to introduce sample and GSH
solutions into the chip.
2.3. Screen-Printed Electrodes (SPEs)
Unmodified SPEs (DropSens) were used for the mimicry of phase II metabolism. A three electrode
configuration (Figure 1), composed of a carbon working (4 mm diameter) electrode, a carbon counter
electrode, and a silver reference electrode. The dimensions of the sensor were 3.4 cm× 1.0 cm× 0.05 cm
(length × width × height). An edge connector DRP-DSC (DropSens) served as an interface between
the SPE and potentiostat.
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Figure 1. Unmodified screen-printed electrode (SPE) with a three electrode configuration. 
2.4. Microfluidic Device with an SPE 
An SPE was integrated with a serpentine reaction channel into a polymeric chip for monitoring 
phase II metabolism. The working principle involved the electrochemical generation of the phase I 
intermediates within the SPE cell and their subsequent conjugation with GSH in a serpentine 
reaction channel. 
2.4.1. Time of Electrolysis in the SPE Cell 
Investigations on SPEs suggested that 0.5 min of control potential electrolysis (CPE) was sufficient 
for GSH-adduct detection in MS [21]. Thus equal or longer durations of electrolysis are required 
within the SPE cell. Considering the delicate structure of the integrated chip and the capabilities in MS, 
the selected flow rate range was from 2.5 µL·min−1 to 50 µL·min−1. The volume of SPE cell was 32 µL to 
ensure longer durations of electrolysis (t > 0.5 min) at the selected flow rate range, Table 1. 
Table 1. Effect of flow rate in metabolic synthesis and GSH conjugation. 
Flow Rate 
(µL·min−1) 
Time of Electrolysis 
(min) 
Combined Flow Rate
(µL·min−1) 
Time of GSH Conjugation 
(min) 
2.5 12.8 5.0 4.8 
5 6.4 10 2.4 
10 3.2 20 1.2 
20 1.6 40 0.6 
30 1.1 60 0.4 
60 0.6 100 0.2 
2.4.2. Time of GSH Conjugation in a Serpentine Channel 
In a serpentine reaction channel, the laminar flows of test sample and GSH are expected to 
diffuse and then to react covalently. The width of the serpentine channel is a key parameter for 
determining the time of diffusion mixing. As shown in Equation (1), a width of 0.01 cm, at a 
diffusion coefficient of 3.0 × 10−6 cm2/s, provided a diffusion mixing of 0.28 min. The calculated times 
for GSH conjugation, at the combined flow rate range of 5 µL·min−1 to 100 µL·min−1, are shown in 
Table 1. At all flow rates, the duration of conjugation is longer or close to the time required for 
diffusion mixing: 
ݐ = (ݓ݅݀ݐℎ)
ଶ
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2.4.3. Fabrication of Chip 
The chip was fabricated from three polycarbonate wafers of 3.3 cm × 1.7 cm (length × width), 
bonded together with silicone and double adhesive tape (Figure 2). A 32 µL SPE cell, a 20 µL 
serpentine reaction channel of 120 mm × 0.01 cm × 20 µm (length × width × depth) and a side channel 
of 80 mm × 0.04 cm × 20 µm (length × width × depth) were drilled into the middle layer (Figure 2B) 
Figure 1. Unmodified screen-printed electrode (SPE) with a three electrode configuration.
2.4. Microfluidic Device with an SPE
An SPE was integrated with a serpentine reaction channel into a polymeric chip for monitoring
phase II metabolism. The working principle involved the electrochemical generation of the phase I
intermediates within the SPE cell and their subsequent conjugation with GSH in a serpentine
reaction channel.
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f r GSH-adduct detection in MS [21]. Thus equal or longer durations of electrolysis are required within
the SPE c ll. Consideri g the delicate structure of the integrat d chip and the capabilities in MS, the
sel cted flow rate range was from 2.5 µL·min−1 to 50 µL·min−1. The volu e of SPE cell as t
l ti f l t l i (t 0.5 min) at the selected flow rate range, Table 1.
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Flow Rate
(µL·min−1)
Time of Electrolysis
(min)
Combined Flow Rate
(µL·min−1)
Time of GSH
Conjugation (min)
2.5 12.8 5.0 4.8
5 6.4 10 2.4
10 3.2 20 1.2
20 1.6 40 0.6
30 1.1 60 0.4
60 0.6 100 0.2
2.4.2. Time of GSH Conjugation in a Serpentine Channel
In a serpentine reaction channel, the laminar flows of test sample and GSH are expected to diffuse
and then to react covalently. The width of the serpentine channel is a key parameter for determining
the time of diffusion mixing. As shown in Equation (1), a width of 0.01 cm, at a diffusion coefficient of
3.0 × 10−6 cm2/s, provided a diffusion mixing of 0.28 min. The calculated times for GSH conjugation,
at the combined flow rate range of 5 µL·min−1 to 100 µL·min−1, are shown in Table 1. At all flow rates,
the duration of conjugation is longer or close to the time required for diffusion mixing:
t =
(width)2
2x (di f f usion coe f f icient)
(1)
2.4.3. Fabrication of Chip
The chip was fabricated from three polycarbonate wafers of 3.3 cm × 1.7 cm (length × width),
bonded together with silicone and double adhesive tape (Figure 2). A 32 µL SPE cell, a 20 µL serpentine
reaction channel of 120 mm × 0.01 cm × 20 µm (length × width × depth) and a side channel of
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80 mm × 0.04 cm × 20 µm (length × width × depth) were drilled into the middle layer (Figure 2B) by
a computer numerical control (CNC) machine (Daltron, New Hampshire, NH, USA). The inlets and
outlet were drilled in wafer (Figure 2A), and wafer (Figure 2C) served as a base for the chip. The full
design of the proposed chip is shown in Figure 2D.
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2.5. Optimization of SPEs 
Prior to microfluidic investigations, the conditions for DOPA metabolism were optimized on 
bare SPEs. A new SPE was used for each experiment, considering the disposable nature of the 
sensor. For both kinetic and synthetic applications, 50 µL of sample solution were loaded into the 
three electrode configuration. Oxidation products were subsequently detected by offline ESI/MS.  
2.6. Chip/ESI-MS 
The integrated chip was coupled online to ESI/MS via transfer capillaries (Figure 3). DOPA  
(2.5 × 10−5 M) in 0.1 M ammonium acetate was infused into the SPE cell at a constant flow rate of  
5 µL·min−1 and electrolyzed for 6.4 min. GSH (5 × 10−5 M) in 0.1 M of ammonium acetate was also 
infused at the same flow rate towards the serpentine channel and conjugated covalently with the 
oxidation products for 2.4 min. It should be emphasized that a new chip was used for each 
electrolysis. 
Figure 2. Fabrication process. (A) Top wafer with inlets and outlet; (B) middle wafer containing the
32 µL SPE cell and 20 µL serpentine reaction channel; (C) base layer and (D) full design of the chip.
2.5. pti ization of SPEs
Prior to icrofluidic investigations, the conditions for P etabolis ere opti ized on
bare SPEs. A ne SPE as used for each experi ent, considering the disposable nature of the
sensor. For both kinetic and synthetic applications, 50 µL of sa ple solution ere loaded into the
three electrode configuration. xidation products ere subsequently detected by offline ESI/ S.
2.6. Chip/ESI-MS
The integrated chip was coupled online to ESI/MS via transfer capillaries (Figure 3). DOPA
(2.5 × 10−5 M) in 0.1 M ammonium acetate was infused into the SPE cell at a constant flow rate of
5 µL·min−1 and electrolyzed for 6.4 min. GSH (5 × 10−5 M) in 0.1 M of ammonium acetate was also
infused at the same flow rate towards the serpentine channel and conjugated covalently with the
oxidation products for 2.4 min. It should be emphasized that a new chip was used for each electrolysis.
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3. Validation of SPEs 
3.1. Electrochemical Behavior of DOPA 
Cyclic voltammetry was used to study the electrochemical behaviour of DOPA on an SPE. The 
voltammetric response of DOPA (2.5 × 10−5 M) in 0.1 M phosphate buffer (pH 5) was recorded over 
the potential range of 0.3–0.6 V and at 0.155 V·s−1 scan rates. A redox pair was obtained with an 
oxidative peak at 0.128 V and a reductive peak at −0.08 V (Figure 4). The separation peak potential 
(ΔΕρ) was found to be 0.208 V, indicating a quasi-reversible process [23]. 
 
Figure 4. Cyclic Voltammograms of (A) Blank electrolyte solution, (B) DOPA (2.5 × 10−5 M). 
3.2. Effect of pH 
Cyclic voltammograms of DOPA (2.5 × 10−5 M) were recorded in different pH values (0.1 M 
phosphate buffers at pH 1, 2, 3, 4, 5, 6, 7, 8) at 0.1 V·s−1 scan rates. 
3.2.1. Participation of Protons 
A linear relationship was obtained between the anode potential (Epa) and pH, suggesting the 
participation of protons during the electrochemical process (Figure 5). The anode potential shifted to 
more negative values as pH increased. The obtained slope 0.0514 V·pH−1 was close to the Nernestian 
slope of 0.059 V·pH−1 [24], implying the involvement of the same number of protons and electrons. 
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3.2.2. Stability Studies 
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Figure 6. Product stability as a function of pH. Not visible error bars: when the symbol size is larger
than the error bar.
3.2.3. Current
The concentration of the electrogenerated product is directly proportional to the obtained
current [26]. Herein, the highest signals for both Ipa and Ipc were observed at pH 4 (Figure 7). For pH
values of 1–3 and 5–8, signals were low, implying less product formation. The obtained peak currents
were in good agreement with the stability studies since at pH 8 the product was unstable and lower
currents were generated.
3.3. Effect of Scan Rate
Useful infor ation regarding the electroche ical reaction echanis s can be acquired fro
the potential scan rate. Therefore, the electroche ical response of DOPA (2.5 × 10 M) in 0.1
phosphate buffer (pH 5) was investigated at different scan rates from 0.02 V·s−1 to 0.155 V·s−1 by
cyclic voltammetry (Figure 8A). The results illustrated quasi-reversible kinetics [27,28]. Epa and Epc
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shifted to more positive and more negative values, respectively (Figure 8B). Also, the ∆ε$ increased
with the increase in scan rate (Figure 8C) while a linear relationship was obtained between the Ip and
square root (SQRT) of scan rate (Figure 8D).
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The transport mode of electroactive material towards the electrode surface is determined by the
plot of logarithm current (Ip) versus logarithm scan rate (V). Slopes close to 1 suggest an adsorption
process, below 0.5 a diffusion process and values between 0.5 and 1, a mixture of both diffusion and
adsorption [27–29]. A linear relationship was found between the logarithm of Ipa and Ipc with the
logarithm of scan rate (V), Equations (2) and (3), and the obtained slopes were 0.52 and 0.6 respectively,
illustrating an adsorption-diffusion controlled process:
log Ipa = 0.52 log V − 2.5, R2 = 0.994 (2)
log Ipc = 0.60 log V − 2.4, R2 = 0.995 (3)
These particular findings are in a good agreement with previous published data of DOPA in solid
electrodes [30–32]. As concluded, DOPA was oxidized electrochemically on the surface of a bare SPE
into the corresponding dopaminoquinone, via the transfer of two electrons and two protons.
3.4. Cyclic Voltammetry in the Presence of GSH
Oxidation of DOPA (2.5 × 10−5 M) in the presence of various GSH concentrations from 0 M to
2.5 × 10−4 M was studied by cyclic voltammetry. As seen in Figure 9, the voltammetric response
of DOPA changed after the additions of GSH, illustrating the formation of a GSH-adduct and,
as a consequence, the trapping of dopaminoquinone. Ipc reduced with the increase of GSH, reaching
almost an irreversible system at the highest GSH concentration (2.5 × 10−4 M). The particular
electrochemical response explained the consumption of dopaminoquinone through GSH conjugation.
In addition, Ipa increased and Epa shifted to more positive values, further implying the formation of
a GSH-adduct metabolite, which was also electroactive.
 , ,   f  
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presence of 2.5 × 10−4 M GSH. (E) GSH (5 × 10−5 M). 
3.5. Potential Optimization  
The oxidative potential was optimized from 0.17 V to 0.52 V, over a mass transport limit with 
increasing steps of 0.05 V, as shown in Figure 10. The selection of potentials was based on the 
obtained voltammograms in Figure 9, in the presence of 5 × 10−5 M of GSH. The DOPA-GSH adduct 
(m/z 459) was detectable at all potentials and the parent compound was depleted. The optimum 
potential was found to be 0.27 V, since this is when higher yields were obtained, as indicated by the 
intensities from MS. 
Figure 9. Cyclic voltammetry of DOPA (2.5 × 10−5 M) as a function of GSH addition. (A) DOPA
(2.5 × 10−5 M). (B) In the presence of 5 × 10−5 M GSH. (C) In the presence of 1.24 × 10−5 M GSH.
(D) In the presence of 2.5 × 10−4 M GSH. (E) GSH (5 × 10−5 M).
3.5. Potential Optimization
The oxidative potential was optimized from 0.17 V to 0.52 V, over a mass transport limit with
increasing steps of 0.05 V, as shown in Figure 10. The selection of potentials was based on the obtained
voltammograms in Figure 9, in the presence of 5 × 10−5 M of GSH. The DOPA-GSH adduct (m/z 459)
was detectable at all potentials and the parent compound was depleted. The optimum potential was
found to be 0.27 V, since this is when higher yields were obtained, as indicated by the intensities
from MS.
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. . a sti e lectrol sis
I order to generate higher metabolite yields, the optimized potential was held consta t for 30 min
over the same conditi s. At the end of electrolysis, a brownish colour change was obtained in solution,
which was not seen in pot ntial o timiz ti n or during cyclic voltammetry. The brownis colour was
attributed to new metab lite with /z of 301, hich was found after prolonged electrolysis. As higher
yi lds of dopaminoquinone were roduced, this allow d further reactions to occur. Intermediates
with dark colours have been reported in literatur , as a part of DOPA phase 1 metabolism [22].
The glutathione disulphide (GSSG) was also obtained, confirming th ability of SPEs to generate
multiple metabolites in extended tim s of lectrolysis. The expected DOPA-GSH adduct was formed
in lower intensiti s, compared to the new metabolite (m/z of 301) (Figur 11).
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3.7. Proposed Reaction echanis for Electroche ical etabolis
ccording to the obtained /z, at the opti ized potential of 0.27 , P as oxidized via the
transfer of two electrons and two protons into the reactive dopaminoquinone, Scheme 1. Subsequently,
the phase I metabolite followed three main pathways leading to DOPA-GSH adduct, GSS , and DOPA
dimer. The first pathway involved the covalent conjugation of the electrogenerated dopaminoquinone
with GSH, forming the expected phase II DOPA-GSH adduct (m/z 459). In the second pathway, a series
of electrochemical and chemical steps were taken, leading to a dimer (m/z 301) with a brownish
colour. In particular, dopaminoquinone was converted chemically into leucodopaminochrome
via intramolecular cyclization, and subsequently electrochemically oxidised through the transfer
of two electrons and two protons to the corresponding aminochrome. A polymerisation process
between aminochrome and parent DOPA compound generated the phase I DOPA dimer metabolite.
The side products were in an agreement with the relevant literature in electrochemical [31] and
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conventional metabolism [22,33]. Finally, the third pathway involved a catalytic process among the
dopaminoquinone with GSH, causing the regeneration of the DOPA and the formation of the GSSG
(m/z 612).
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4. icrofluidic evice ith an SPE
4.1. Functionality of Chip
The functionality of the chip in generating phase II GSH-adducts was initially investigated using
APAP, considering its simple and well-studied electrochemical metabolism.
4.1.1. Cyclic Voltammetry on Chip
During validation studies, cyclic voltammetry was used to determine the potential range for
CPE. Cyclic voltammograms of APAP (1 × 10−3 M) in 0.1 M ammonium acetate were recorded on the
chip at stop flow conditions and at various flow rates from 2.5 µL·min−1 to 50 µL·min−1. As shown
in Figure 12, a well-defined quasi-reversible pair was obtained, illustrating the capability of chip to
determine a potential range. Shifts in potentials have been obtained mainly in higher flow rates due to
an enhanced material adsorption.
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complete mimicry of the phase I (dehydrogenation) and phase II (GSH conjugation) reactions.  
4.1.3. Online Coupling 
CPE in the potential range of 0.4 V to 0.75 V was recorded, in 0.05 V steps to determine the 
optimum potential for APAP-GSH formation. The conditions applied were the same as in offline 
coupling. The oxidation potential was 0.35 V, as determined by cyclic voltammetry; however, the 
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Figure 12. Cyclic voltammetry in the presence of APAP (1 × 10−3 M). (A) Off chip; (B) Stop flow;
(C) 2.5 µL·min−1; (D) 5 µL·min−1; (E) 20 µL·min−1; (F) 50 µL·min−1.
. . . lectr l sis j i
f ti li t i i e r ti s II - t s i sti t ffli , i
r e. AP P (2.5 × 10−5 M) in 0.1 M ammonium acetate (pH 7.4) was infused into
the surface of SPE and electrolysed for 6.4 min, at 0.5 V. The potential was not optimized; however, it
ass transport limit, since it was 0.1 V higher than the obtained oxidative peak in
cyclic voltammetry. Subsequently, the efflu nt was collected and analyse by ESI/MS. The APAP-GSH
adduct (m/z 456.84) was generated successfully, as seen in Figure 13, confirming the complete mimicry
of the phase I (dehydrogenation) and phase II (GSH conjug tion) reactions.
4.1.3. Online Coupling
CPE in the potential range of 0.4 V to 0.75 V was recorded, in 0.05 V steps to deter ine the
opti u potential for APAP-GSH for ation. The conditions applied were the sa e as in offline
coupling. The oxidation potential was 0.35 V, as deter ined by cyclic volta etry; however, the
investigated potential range was at least 0.05 V higher to ensure minimum interference from kinetics.
At the oxidative peak the electrochemical reaction is not completed yet and a strong competition is
created between the electron transfer and mass transport. Thus, maximum metabolite yields can be
obtained at higher potentials, where the electrochemical reaction leads gradually to depletion and the
system is dominated by ass transport. As seen in Figure 14, the APAP-GSH adducts and GSSG were
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formed, suggesting the capability of the chip to mimic two metabolic pathways, simultaneously over
flow conditions. The optimum potential for the APAP-GSH adducts was found to be 0.5 V.Sensors 2016, 16, 1418 12 of 15 
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4.1.4. Potential Opti ization for the Generation of DOPA-GSH Adduct
Experi ents on an SPE confir ed the capability of the particular sensors to i ic ultiple
DOPA etabolites. The great instability of dopa inoquinone at pH 7.4 per itted the generation of
leucodopa inochro e. For this reason, the pH of DOPA solution was decreased to pH 7, aiming
for the total conversion of dopaminoquine into the required phase II adduct. In addition, the
time of electrolysis was also reduced significantly to 6.4 min in order to prevent the dominance
of leucodopaminochrome over GSH-adduct. As seen in Figure 15, the DOPA-GSH adduct (m/z 459)
was successfully formed at all potentials and the generation of the phase I dimer was avoided.
The maximum DOPA-GSH adduct formation was obtained at 0.37 V. However, the optimum
potential on the bare SPE was found to be at 0.27 V. This observation is due to the surface chemistry
having changed over flow conditions, leading to strong adsorption phenomena. The potential
difference did not limit the functionality of the chip, since the DOPA-GSH was successfully generated
and the aim of monitoring the phase II metabolism of DOPA was fulfilled. The obtained ion intensities
for the DOPA-GSH adduct were increased from 0.17 V to 0.37 V, and then decreased. Considering that
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SPEs have a limited potential application up to 1 V, as the potentials were approaching the potential
limit, the functionality and the electrochemical stability of the chip gradually started to decline.
Additionally, the catalytic product of GSSG was also obtained as in the bare SPE; the spectra at the
optimized potential of 0.37 V is shown in Figure 16. The ion intensities for the microfluidic device
were lower when compared with earlier investigations on bare SPEs, due to the continuous sample
dilution in a serpentine channel as well as adsorption effects.
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5. Conclusions 
A disposable microfluidic device with an SPE was developed and successfully mimicked the 
phase II metabolism. In particular, an SPE cell was combined with a serpentine channel that allowed 
the generation and detoxification of dopaminoquinone, respectively. A metabolic profile was 
obtained in less than 10 min without the use of any tedious cleaning processes. The total cost for each 
chip was only 5 GBP, providing a cheaper alternative to the current in vitro studies. The proposed 
chip has the potential to be used as a primary screening tool in pharmaceutical and clinical research, 
and thereby complement the current methodologies. 
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5. Conclusions
A disposable microfluidic device with an SPE was developed and successfully mimicked the
phase II metabolism. In particular, an SPE cell was combined with a serpentine channel that allowed
the generation and detoxification of dopaminoquinone, respectively. A metabolic profile was obtained
in less than 10 min without the use of any tedious cleaning processes. The total cost for each chip was
only 5 GBP, providing a cheaper alternative to the current in vitro studies. The proposed chip has the
potential to be used as a primary screening tool in pharmaceutical and clinical research, and thereby
complement the current methodologies.
Acknowledgments: This study has not received any form of financial support.
Sensors 2016, 16, 1418 14 of 15
Author Contributions: R.V. designed and performed the experiments, the data analysis, created and edited the
manuscript and illustration. M.M.N.E. and N.J.B. designed and fabricated the chip. K.J.W. contributed to the
study concept and design, offering supervision together with technical and administrative support throughout
the entire duration of project.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Xu, C.; Li, Y.T.C.; Kong, A.N.T. Induction of phase I, II and III drug metabolism/transport by xenobiotics.
Arch. Pharm. Res. 2005, 28, 249–268. [CrossRef] [PubMed]
2. Iyanagi, T. Molecular mechanism of phase I and phase II drug-metabolizing enzymes: Implications for
detoxification. Int. Rev. Cytol. 2007, 260, 35–112. [PubMed]
3. Jancova, P.; Anzenbacker, P.; Anzenbacherova, E. Phase II metabolizing enzymes. Biomed. Pap. 2010, 154,
103–116. [CrossRef]
4. Hayes, J.D.; Flanagan, J.U.; Jowsey, I.R. Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 2005, 45,
51–88. [CrossRef] [PubMed]
5. Alfafara, C.G.; Kanda, A.; Shioi, T.; Shimizu, H.; Shioya, S.; Suga, K. Effect of amino-acids on glutathione
production by sacharromyces-cerevisiaie. Appl. Microbiol. Biotechnol. 1992, 36, 538–540. [CrossRef]
6. Rajasekaran, M.; Abirami, S.; Chen, C. Effects of Single Nucleotide Polymorphisms on Human
N-Acetyltransferase 2 Structure and Dynamics by Molecular Dynamics Simulation. PLoS. ONE 2011,
6, 1–12. [CrossRef] [PubMed]
7. Srivastava, A.; Maggs, J.L.; Antoine, D.J.; Williams, D.P.; Smith, D.A.; Park, B.K. Role of reactive metabolites
in drug-induced hepatotoxicity. In Adverse Drug Reactions; Springer: Heidelberg, Germany, 2010; pp. 165–194.
8. Lohmann, W.; Karst, U. Generation and identification of reactive metabolites by electrochemistry and
immobilized enzymes coupled on-line to liquid chromatography/mass spectrometry. Anal. Chem. 2007, 79,
6831–6839. [CrossRef] [PubMed]
9. Baumann, A.; Karst, U. Online electrochemistry/mass spectrometry in drug metabolism studies: Principles
and applications. Expert Opin. Drug Metab. Toxicol. 2010, 6, 715–731.
10. Van Leeuwen, S.M.; Blankert, B.; Kauffmann, J.M.; Karst, U. Prediction of clozapine metabolism by on-line
electrochemistry/liquid chromatography/mass spectrometry. Anal. Bioanal. Chem. 2005, 382, 742–750.
[CrossRef] [PubMed]
11. Plattner, S.; Pitter, F.; Brouwer, H.J.; Oberacher, H. Formation and Characterization of Covalent Guanosine
Adducts with Electrochemistry—Liquid Chromatography–Mass Spectrometry. J. Chromatogr. B Analyt.
Technol. Biomed. Life Sci. 2012, 883–884, 198–2014. [CrossRef] [PubMed]
12. Lohmann, W.; Hayen, H.; Karst, U. Covalent Protein Modification by Reactive Drug Metabolites Using
Online Electrochemistry/Liquid Chromatography/Mass Spectrometry. Anal. Chem. 2008, 80, 9714–9719.
[CrossRef] [PubMed]
13. Regino, M.C.S; Brajiter-Toth, A. An electrochemical cell for on-line electrochemistry/mass spectrometry.
Anal. Chem. 1997, 69, 5067–5072. [CrossRef]
14. Getek, T.A.; Korfmacher, W.A.; Mcrae, T.A.; Hinson, J.A. Utility of solution electrochemistry mass
spectrometry for investigating the formation and detection of biologically important conjugates of
acetaminophen. J. Chromatogr. A 1989, 479, 245–256. [CrossRef]
15. Lohmann, W.; Karst, U. Simulation of detoxification of paracetamol using on-line electrochemistry/liquid
chromatography/mass spectrometry. Anal. Bioanal. Chem. 2006, 386, 1701–1708. [CrossRef] [PubMed]
16. Van den Brink, F.T.G.; Buter, L.; Odjik, M.; Olthuis, W.; Karst, U.; van den Berg, A. Mass spectrometric
detection of short–lived drug metabolites generated in an electrochemical microfluidic chip. Anal. Chem.
2015, 87, 1527–1535. [CrossRef] [PubMed]
17. Roussel, C.; Dayon, L.; Lion, L.; Rohner, T.C.; Josserand, J.; Ropssier, J.S.; Jensen, H.; Girault, H.H. Generation
of Mass Tags by the Inherent Electrochemistry of Electrospray for Protein Mass Spectrometry. J. Am. Soc.
Mass Spectrom. 2004, 15, 1767–1779. [CrossRef] [PubMed]
18. Miserere, S.; Ledru, S.; Ruille, N.; Criveau, S.; Boujtita, M.; Bedioui, F. Biocompatible carbon-based
screen-printed electrodes for the electrochemical detection of nitric oxide. Electrochem. Commun. 2006,
8, 238–244. [CrossRef]
Sensors 2016, 16, 1418 15 of 15
19. Mistry, K.K.; Layek, K.; Mahapatra, A.; RoyChaudhurib, C.; Sahab, H. A review on amperometric-type
immunosensors based on screen-printed electrodes. Analyst 2014, 139, 2289–2311. [CrossRef] [PubMed]
20. Khaled, E.; Hassan, H.N.A.; Habib, I.H.I.; Metelka, R. Chitosan modified screen-printed carbon electrode for
sensitive analysis of heavy metals. Int. J. Electrochem. Sci. 2010, 5, 158–167.
21. Kauffmann, J.M.; Antwerpen, P.V.; Sarakbi, A.; Feier, B.; Tarik, S.; Aydogmus, Z. Utility of Screen Printed
Electrodes for in Vitro Metabolic Stability Assays: Application to Acetaminophen and its Thioconjugates.
Electroanalysis 2011, 23, 2643–2650. [CrossRef]
22. Monoz, P.; Melendez, C.; Paris, I.; Sequra-Aquilar, J. Molecular and neurochemical mechanism dopamine
oxidation to 0-quinone in Parkinson disease pathogenesis. In Toxicity and Autophage in Neurodegenerative
Disorders; Springer: Basel, Switzerland, 2015; pp. 205–223.
23. Eklund, J.C.; Alan, B.M.; Alden, J.A.; Gompton, R.G. Perspectives in modern voltammetry: Basic Concepts
and Mechanistic Analysis. Adv. Phys. Org. Chem. 1999, 2, 1–120.
24. Mahanthesha, K.R.; Kumara-Swamy, B.E.; Vasantakumar-Pai, K.; Chandra, U.; Sherigara, B.S. Cyclic
Voltammetric Investigations of Dopamine at Alizarin Modified Carbon Paste Electrode. Int. J. Electrochem. Sci.
2010, 5, 1962–1971.
25. Nematollahi, D.; Shayani-Jam, H.; Alimoradi, M.; Niroomand, S. Electrochemical oxidation of acetaminophen
in aqueous solutions: Kinetic evaluation of hydrolysis, hydroxylation and dimerization processes.
Electrochim. Acta 2009, 54, 7407–7515. [CrossRef]
26. Joseph, B.; Justice, J.R. Introduction to in Vivo Voltammetry. In Voltammetry in the Neurosciences; Adams, R.N.,
Justice, J.B., Eds.; Humana Press: New York, NY, USA, 1987; pp. 15–17.
27. Bagheri, A.; Hosseini, H. Electrochemistry of raloxifene on a glassy carbon electrode and its determination in
pharmaceutical formulation and human plasma. Bioelectrochemistry 2012, 88, 164–170. [CrossRef] [PubMed]
28. Hasan, M.M.; Hossain, M.E.; Mamum, M.A.; Ehsan, M.Q. Study of redox behavior of Cd(II) and interaction
of Cd(II) with proline in the aqueous medium using cyclic voltammetry. J Saud. Chem. Soc. 2012, 16, 145–151.
29. Ndangli, P.M.; Jijana, A.N.; Olowu, R.N.; Mailu, S.N.; Ngece, F.R.; Williams, A.; Waryo, T.T.; Baker, P.G.L.
Impedimetric Response of a Label-Free Genosensor Prepared on a 3-Mercaptoprionic Acid Capped Gallium
Selenide Nanocrystal Modified Gold Electrode. Int. J. Electrochem. 2011, 6, 1438–1453.
30. Ahuja, S.; Jespersen, N. Modern Instrumental Analysis; Elsevier: Kidlington, UK, 2006.
31. Ke, N.J.; Lu, S.H.; Cheng, S.H. A strategy for the determination of dopamine at a bare glassy carbon electrode:
p-Phenylenediamine as a nucleophile. Electrochem. Commun. 2006, 8, 1514–1520. [CrossRef]
32. Liu, C.Y.; Liu, Z.Y.; Peng, R.; Zhong, Z.C. Quasireversible Process of Dopamine on Copper-Nickel Hydroxide
Composite/Nitrogen Doped Graphene/Nafion Modified GCE and Its Electrochemical Application. J. Anal.
Methods Chem. 2014, 2014, 1–7. [CrossRef] [PubMed]
33. Spina, M.B.; Cohen, G. Dopamine turnover and glutathione oxidation: Implications for Parkinson disease.
Proc. Natl. Acad. Sci. USA 1989, 86, 1398–1400. [CrossRef] [PubMed]
© 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
